Arnold & Porter's 2024 Benchmark Survey Report on the Convergence of Life Sciences and Artificial Intelligence

While many life sciences companies are still in the early stages of evaluating and implementing various artificial intelligence use cases, the deployment of such tools is scaling rapidly. Committed to serving our client needs in this rapidly evolving area, Arnold & Porter recently surveyed 100 senior executives and department heads in North America and Europe about the ways in which AI is reshaping biomedical product design and discovery, development, commercialization, and stewardship. Whether your company has a sophisticated AI strategy and infrastructure or emerging plans in this area, please join this special program where we will reveal the key takeaways from our benchmark survey, as well as insights on risk assessment and mitigation strategies to ensure that your company can capitalize on the innovations without undue risk.

We invite you to join this interactive webinar with questions.